We are live on ! Find out more
CCM

Cupps Capital Management Portfolio holdings

AUM $231M
1-Year Est. Return 49.73%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+49.73%
3 Year Est. Return
+212.7%
5 Year Est. Return
10 Year Est. Return
AUM
$231M
AUM Growth
-$156M
Cap. Flow
-$194M
Cap. Flow %
-83.99%
Top 10 Hldgs %
24.21%
Holding
206
New
45
Increased
20
Reduced
112
Closed
29

Sector Composition

1 Technology 39.39%
2 Healthcare 24.2%
3 Consumer Discretionary 10.03%
4 Industrials 9.46%
5 Real Estate 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLNX
201
DELISTED
Mellanox Technologies, Ltd.
MLNX
-43,696
Closed -$2.1M
ZOES
202
DELISTED
Zoe's Kitchen, Inc.
ZOES
-37,650
Closed -$1.36M
MBLY
203
DELISTED
Mobileye N.V.
MBLY
-30,535
Closed -$1.41M
HW
204
DELISTED
Headwaters Inc
HW
-59,277
Closed -$1.06M
WWAV
205
DELISTED
The WhiteWave Foods Company
WWAV
-28,641
Closed -$1.34M
RHT
206
DELISTED
Red Hat Inc
RHT
-5,235
Closed -$380K

Similar funds

Cupps Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Cupps Capital Management held 206 positions worth $231M, down 40% from $387M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Cupps Capital Management withdrew a net $194M in Q3 2016, closing 29 positions and reducing 112 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.68M position sold in full.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Cupps Capital Management opened a new position in Medidata Solutions, Inc. worth $2.63M.

  • Cupps Capital Management's largest Q3 2016 buy was Medidata Solutions, Inc.: 47,254 shares worth $2.63M.
  • Cupps Capital Management added most to Cavium, Inc. in Q3 2016, an estimated $1.52M increase.
  • Cupps Capital Management's biggest Q3 2016 reduction was Abiomed Inc, cutting an estimated $9.12M.
  • Cupps Capital Management fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $3.68M.
  • Cupps Capital Management's ten largest holdings make up 24% of its $231M portfolio in Q3 2016.
  • Cupps Capital Management opened 45 new positions and closed 29 in Q3 2016.
  • Cupps Capital Management's portfolio value fell 40% quarter-over-quarter to $231M.

Based on Cupps Capital Management's 13F filing for Q3 2016, filed 11 Oct 2016.